Goat Antibody Laboratories manufactures the goat anti-human dr5 antibody reagents distributed by Genprice. The Goat Anti-Human Dr5 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact goat Antibody. Other Goat products are available in stock. Specificity: Goat Category: Anti-Human Group: Dr5 Antibody
Dr5 Antibody information
DR5 antibody |
|
70R-51347 |
Fitzgerald |
100 ul |
EUR 242 |
|
|
|
Description: Purified Polyclonal DR5 antibody |
DR5 Antibody |
|
3062-100 |
Biovision |
each |
EUR 379.2 |
DR5 Antibody |
|
3062-30T |
Biovision |
each |
EUR 175.2 |
DR5 Antibody |
|
24041 |
SAB |
100ul |
EUR 479 |
DR5 Antibody |
|
24041-100ul |
SAB |
100ul |
EUR 468 |
DR5 antibody |
|
10R-6672 |
Fitzgerald |
100 ug |
EUR 418.8 |
|
Description: Mouse monoclonal DR5 antibody |
DR5 antibody |
|
10R-6673 |
Fitzgerald |
100 ug |
EUR 418.8 |
|
Description: Mouse monoclonal DR5 antibody |
DR5 Antibody |
|
2019-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
|
|
Description: DR5 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently. Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-κB. |
DR5 Antibody |
|
2019-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
|
|
Description: DR5 Antibody: Apoptosis is induced by certain cytokines including TNF and Fas ligand in the TNF family through their death domain containing receptors. TRAIL/Apo2L is a new member of the TNF family. DR4 was recently identified as the receptor for TRAIL. A novel death domain containing receptor for TRAIL was more recently identified and designated DR5, Apo2, TRAIL-R2, TRICK2, or KILLER by several groups independently. Like DR4, DR5 transcript is widely expressed in normal tissues and in many types of tumor cells. DR5 binds to TRAIL and mediates TRAIL induced cell death. Overexpression of DR5 induces apoptosis and activates NF-κB. |
DR5 Antibody |
|
49563 |
SAB |
100ul |
EUR 499 |
DR5 Antibody |
|
49563-100ul |
SAB |
100ul |
EUR 399.6 |
DR5 Antibody |
|
49563-50ul |
SAB |
50ul |
EUR 286.8 |
DR5 Antibody |
|
E300299 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
DR5 Antibody |
|
E301389 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
